Hydroxychloroquine Market , By Disease Indication (Malaria, Coronavirus Disease, Lupus Erythematosus, and Rheumatoid Arthritis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), by and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)-Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Hydroxychlorquine exhibits the potential invitro activity against viruses including influenza, malaria, coronavirus, and many other diseases. The drug is under investigation to determine its efficacy for the treatment of novel coronavirus disease (COVID 19). According to the studies conducted in Wuhan, the body temperature recovery time and the cough remission time of coronavirus patients were significantly reduced with hydroxycloroquine and chloroquine treatment.Despite the absence of strong evidence, the demand for hydroxychloroquine has spiked due to the coronavirus (COVID 19) outbreak. However, the doses of hydroxychloroquine need to be monitored, as its overdose can have dangerous side effects such as drowsiness, visual disturbances, cardiovascular collapse, convulsions, hypokalemia, rhythm, ventricular tachycardia, and ventricular fibrillation. This may lead to sudden respiratory and cardiac arrest, which can be fatal.
Market Dynamics
The increasing adoption of inorganic growth strategies such as partnerships and collaborations by key players to evaluate the efficacy of hydroxchloroquine tablets for the treatment of patients with coronavirus disease (COVID 19) are expected to propel the market growth over the forecast period. For instance, on March 27, 2020, Rising Pharma Holdings Inc., a pharmaceutical company, entered into a collaborative agreement with the Division of Infectious Disease and International Medicine at the University of Minnesota, Department of Infectious Disease, to explore hydroxchloroquine as preventive treatment for coronavirus disease (COVID 19).
Key features of the study:
This report provides in-depth analysis of the global hydroxchloroquine market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global hydroxchloroquine market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Sanofi, Amneal Pharmaceuticals, LLC, Laurus Labs, Zydus Group, Prasco, LLC, Dr. Reddy's Laboratories, Ltd, Cadila Pharmaceuticals, Novartis AG, Concordia Pharmaceuticals Inc. (A subsidiary of Advanz Pharma), Covis Pharma GmbH, Cardinal Health, Aphena Pharma Solutions, Mylan N.V (A subsidiary of Vitris), McKesson Corporation, Teva Pharmaceutical Industries Ltd, Lupin, Sun Pharmaceutical Industries Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future drug launches, disease indication up-gradation, market expansion, and marketing tactics
The global hydroxchloroquine market report caters to various stakeholders in this industry including investors, suppliers, drug manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hydroxchloroquine market.
Detailed Segmentation:
Global Hydroxychloroquine Market, By Disease Indication:
Malaria
Coronavirus
Lupus Erythematosus
Rhematoid Arthritis
Global Hydroxychloroquine Market, Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Hydroxychloroquine Market, By Country:
North America
U.S.
Canada
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC
Israel
Rest of Middle East
Africa
South Africa
Central Africa
North Africa
Company Profiles
Sanofi
Amneal Pharmaceuticals, LLC,
Laurus Labs,
Zydus Group
Prasco, LLC
Reddy's Laboratories, Ltd
Cadila Pharmaceuticals
Novartis AG,
Concordia Pharmaceuticals Inc. (A subsidiary of Advanz Pharma)
Covis Pharma GmbH
Cardinal Health
Aphena Pharma Solutions,
Mylan N.V (A susidary of Vitris)
McKesson Corporation
Teva Pharmaceutical Industries Ltd
Lupin, Sun Pharmaceutical Industries Ltd
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Disease Indication
Market Snippet, By Distribution Channel
Market Snippet, By Country
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Regulatory Scenario
Industry Trends
New Disease Indication Approval/Launches
Promotion And Marketing Initiatives
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
4. Global Hydroxychloroquine Market– COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Hydroxychloroquine Market, By Disease Indication, 2018–2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019–2030
Segment Trends
Malaria
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Coronavirus Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Lupus Erythematosus
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Rheumatid Arthritis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
6. Global Hydroxychloroquine Market, By Distribution Channel, 2018–2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019–2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
7. Global Hydroxychloroquine Market, By Region, 2018–2030, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Regions, 2019–2030
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel 2018 - 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, Distribution Channel, 2018 - 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, Distribution Channel, 2018 - 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, Distribution Channel, 2018 - 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, Distribution Channel, 2018 - 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, Distribution Channel, 2018 - 2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Mn)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Sanofi
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Amneal Pharmaceuticals, LLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Laurus Labs
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Zydus Group
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Prasco, LLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Reddy's Laboratories, Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Cadila Pharmaceuticals
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Novartis AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Concordia Pharmaceuticals Inc. (A subsidiary of Advanz Pharma)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Covis Pharma GmbH
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Cardinal Health
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Aphena Pharma Solutions
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Mylan N.V (A subsidiary of Viatris)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
McKesson Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Teva Pharmaceutical Industries Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Lupin
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Sun Pharmaceutial Industries Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
9. Section
Research Methodology
About Us
*Browse 25 market data tables and 26 figures on “Hydroxychloroquine Market” - Global forecast to 2030